Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010

Vaccine

Volumn 29, Issue 44, 2011, Pages 7727-7732

  Choe, Young June ^a   Cho, Heeyeon ^a   Kim, Sung Nam ^a   Bae, Geun Ryang ^a   Lee, Jong Koo ^a  

^a Korea Centers for Disease Control and Prevention   (South Korea)

Author keywords

AEFI; Influenza; Serious adverse events; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ABSCESS; ACUTE DISSEMINATED ENCEPHALOMYELITIS; ACUTE HEART INFARCTION; ADULT; AGED; ANAPHYLAXIS; ARTICLE; BRADYCARDIA; CELLULITIS; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; ENCEPHALITIS; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; INFANT; INFLUENZA VACCINATION; KOREA; LUNG CONGESTION; LYMPHADENITIS; MALE; MEDICAL RECORD REVIEW; MIXED HEARING LOSS; PERIPHERAL NEUROPATHY; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; STROKE; SYNCOPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG TOXICITY; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 80053594849     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.07.129     Document Type: Article

References (26)

1. Prosser L.A., Bridges C.B., Uyeki T.M., Rego V.H., Ray G.T., Meltzer M.I., et al. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual Life Outcomes 2005, 3:18.
2. Govaert T.M., Dinant G.J., Aretz K., Masurel N., Sprenger M.J., Knottnerus J.A. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ 1993, 307(October (6910)):988-990.
3. Margolis K.L., Nichol K.L., Poland G.A., Pluhar R.E. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA 1990, 264(September (9)):1139-1141.
4. Barry D.W., Mayner R.E., Hochstein H.D., Dunlap R.C., Rastogi S.C., Hannah J.E., et al. Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. Am J Epidemiol 1976, 104(July (1)):47-59.
5. Hambidge S.J., Glanz J.M., France E.K., McClure D., Xu S., Yamasaki K., et al. Safety of trivalent inactivated influenza vaccine in children 6-23 months old. JAMA 2006, 296(October (16)):1990-1997.
6. Rosenberg M., Sparks R., McMahon A., Iskander J., Campbell J.D., Edwards K.M. Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age. Vaccine 2009, 27(July (32)):4278-4283.
7. Vellozzi C., Burwen D.R., Dobardzic A., Ball R., Walton K., Haber P. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine 2009, 27(March (15)):2114-2120.
8. Schonberger L.B., Bregman D.J., Sullivan-Bolyai J.Z., Keenlyside R.A., Ziegler D.W., Retailliau H.F., et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979, 110(August (2)):105-123.
9. Collet J.P., MacDonald N., Cashman N., Pless R. Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee. Advisory Committee on Causality Assessment. Bull World Health Organ 2000, 78(2):178-185.
10. Immunization safety surveillance: guidelines for managers of immunization programmes on reporting and investigating adverse events following immunization (WPRO/EPI/99.01). Geneva: World Health Organization; 1999.
11. Sejvar J.J., Kohl K.S., Gidudu J., Amato A., Bakshi N., Baxter R., et al. Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011, 29(January (3)):599-612.
12. Ruggeberg J.U., Gold M.S., Bayas J.M., Blum M.D., Bonhoeffer J., Friedlander S., et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2007, 25(August (31)):5675-5684.
13. Halperin S., Kohl K.S., Gidudu J., Ball L., Hammer S.J., Heath P., et al. Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007, 25(August (31)):5803-5820.
14. Haber P., Sejvar J., Mikaeloff Y., DeStefano F. Vaccines and Guillain-Barre syndrome. Drug Saf 2009, 32(4):309-323.
15. Liang X.F., Li L., Liu D.W., Li K.L., Wu W.D., Zhu B.P., et al. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. N Engl J Med 2011, 364(February (7)):638-647.
16. Haber P., DeStefano F., Angulo F.J., Iskander J., Shadomy S.V., Weintraub E., et al. Guillain-Barre syndrome following influenza vaccination. JAMA 2004, 292(November (20)):2478-2481.
17. Burwen D.R., Ball R., Bryan W.W., Izurieta H.S., La Voie L., Gibbs N.A., et al. Evaluation of Guillain-Barre syndrome among recipients of influenza vaccine in 2000 and 2001. Am J Prev Med 2010, 39(October (4)):296-304.
18. Hughes R.A., Cornblath D.R. Guillain-Barre syndrome. Lancet 2005, 366(November (9497)):1653-1666.
19. Sencer D.J., Millar J.D. Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis 2006, 12(January (1)):29-33.
20. Iskander J., Broder K. Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience. Expert Rev Vaccines 2008, 7(February (1)):75-82.
21. Han M.K., Huh Y., Lee S.B., Park J.H., Lee J.J., Choi E.A., et al. Prevalence of stroke and transient ischemic attack in Korean elders: findings from the Korean Longitudinal Study on Health and Aging (KLoSHA). Stroke 2009, 40(March (3)):966-969.
22. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003, 348(April (14)):1322-1332.
23. Huynh W., Cordato D.J., Kehdi E., Masters L.T., Dedousis C. Post-vaccination encephalomyelitis: literature review and illustrative case. J Clin Neurosci 2008, 15(December (12)):1315-1322.
24. Coop C.A., Balanon S.K., White K.M., Whisman B.A., Rathkopf M.M. Anaphylaxis from the influenza virus vaccine. Int Arch Allergy Immunol 2008, 146(1):85-88.
25. Keller-Stanislawski B., Heuss N., Meyer C. Adverse events following immunisation in Germany from 1.1.2001 to 31.12.2003. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2004, 47(December (12)):1151-1164.
26. Braun M.M., Ellenberg S.S. Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994. J Pediatr 1997, 131(October (4)):529-535.